Skip to content Skip to footer
Inrebic: Benefits, Reviews, Info, Side Effects!
Rx Details
Inrebic
Fedratinib, TG-101348
Fedratinib
Prescription
Medication
Drugs
Prescription Only
reduction of spleen size, improvement of symptoms in myelofibrosis, potential increase in overall survival, oral administration, once-daily dosing
Abdominal Pain, Anemia, Decreased Appetite, Diarrhea, Dizziness, Fatigue, Fever, Headache, Muscle Spasms, Nausea, Vomiting, Weight Loss
Inrebic (fedratinib) is a medication used to treat certain types of myelofibrosis, a bone marrow disorder. The typical starting dosage for Inrebic is 400 mg taken orally once daily. However, the exact dosage may vary based on individual patient needs, tolerability, and specific medical conditions. It’s important for patients to follow their healthcare provider’s instructions regarding dosage and administration. Always consult with a healthcare professional for personalized medical advice.
Myelofibrosis
Inrebic has a favorable safety profile.
No Interactions Reported
$10,000 – $12,000
$15,000

A Synopsis of

Inrebic

Inrebic, also known as fedratinib, is a medication that has been approved by the FDA for the treatment of myelofibrosis, a rare type of blood cancer that affects the bone marrow. This drug works by targeting specific enzymes that are involved in the growth and survival of cancer cells, helping to slow down the progression of the disease.

Patients with myelofibrosis often experience symptoms such as fatigue, enlarged spleen, and bone pain, which can significantly impact their quality of life. Inrebic has been shown to help reduce these symptoms and improve overall well-being in patients with this condition.

It is important to note that Inrebic is not a cure for myelofibrosis, but it can help to manage the symptoms and slow down the progression of the disease. Like all medications, Inrebic may cause side effects in some patients, such as nausea, diarrhea, and low blood cell counts. It is important for patients to discuss these potential side effects with their healthcare provider before starting treatment.

As a medical professional, I recommend that patients with myelofibrosis work closely with their healthcare team to determine if Inrebic is the right treatment option for them. It is important to follow the prescribed dosage and schedule, as well as to report any side effects or concerns to your healthcare provider.

Overall, Inrebic is a valuable treatment option for patients with myelofibrosis, offering hope for improved symptom management and quality of life. If you have any questions or concerns about this medication, please do not hesitate to reach out to your healthcare provider for more information.

RxDb Legal Disclaimer

The information provided on RxDB.net is for informational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional, such as a doctor or pharmacist, for any questions or concerns regarding your health, medications, or medical conditions. Reliance on any information provided on this website is solely at your own risk. RxDB.net does not provide medical or pharmaceutical services and is not liable for any decisions made based on the information contained herein.

PAGE LAST UPDATED

Health Education Through Aggregation

Sign up for the Rx Database Newsletter!
Menu
Questions?

Website By Foxco © 2025. All rights reserved.

0
Would love your thoughts, please comment.x
()
x
en_USEN